SPAG9 and chronic myelogenous leukemia, BCR-ABL1 positive: Sperm-associated antigen 9 (SPAG9) mRNA and protein were found to be expressed in CML patients (88%) and have been associated with humoral response against this antigen in 90% of the cases, suggesting it as a potential biomarker and/or immunotherapeutic target [12].